Creating the future of medicine in the Bay Area

At AbbVie, we are combining our historic legacy in biopharma with the spirit of California innovation. Our team in South San Francisco is pushing the limits of science and technology and driving the discovery and delivery of innovative treatments for cancer.

Committed to transforming standards of care

by advancing cancer research and the development of new treatments for a range of blood and other forms of cancer


with 480,000 square feet of R&D labs and offices

On-site amenities

including the 50,000 square feet Traverse amenity building next door, offering a communal food hall, fitness club, and gathering space

Pioneering breakthroughs for patients

We discover and develop innovative medicines that help solve serious health issues for people around the world. In South San Francisco, we are driving AbbVie’s leadership in oncology and immunology, and using precision medicine to unlock more targeted treatments for patients. Beyond South San Francisco, we have a presence throughout the Bay Area, which includes sites that became part of AbbVie through our acquisition of Allergan in 2020.

Our unrelenting spirit of innovation

Dynamic scientific minds with strong values are essential to delivering on the promise of our R&D efforts. We are a passionate, diverse, equitable, and inclusive organization with a culture that supports bold ideas. With global opportunities in more than 175 countries and 60 disease areas, AbbVie provides challenging work that aims to deliver life-changing impact for patients.  

Bay area focus areas

Our work spans from early research and discovery to delivery of our medicines with focus areas in: 

  • Immuno-Oncology
  • Tumor Targeting
  • Tumor Dependencies
  • Precision Medicine